These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 8178330)
1. Inactivation of lipid-enveloped and non-lipid-enveloped model viruses in normal human plasma by crosslinked starch-iodine. Highsmith FA; Xue H; Caple M; Walthall B; Drohan WN; Shanbrom E Transfusion; 1994 Apr; 34(4):322-7. PubMed ID: 8178330 [TBL] [Abstract][Full Text] [Related]
2. Viral inactivation of vesicular stomatitis virus in normal human serum by cross-linked polyvinylpyrrolidone. Highsmith FA; Caple M; Walthall B; Shanbrom E; Drohan WN J Infect Dis; 1993 May; 167(5):1027-33. PubMed ID: 8387559 [TBL] [Abstract][Full Text] [Related]
3. Iodine-mediated inactivation of lipid- and nonlipid-enveloped viruses in human antithrombin III concentrate. Highsmith F; Xue H; Chen X; Benade L; Owens J; Shanbrom E; Drohan W Blood; 1995 Jul; 86(2):791-6. PubMed ID: 7606009 [TBL] [Abstract][Full Text] [Related]
4. New methods for inactivation of lipid-enveloped and non-enveloped viruses. Miekka SI; Busby TF; Reid B; Pollock R; Ralston A; Drohan WN Haemophilia; 1998 Jul; 4(4):402-8. PubMed ID: 9873761 [TBL] [Abstract][Full Text] [Related]
5. Inactivation of viruses in blood with aluminum phthalocyanine derivatives. Horowitz B; Williams B; Rywkin S; Prince AM; Pascual D; Geacintov N; Valinsky J Transfusion; 1991 Feb; 31(2):102-8. PubMed ID: 1847558 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of lipid-enveloped viruses in labile blood derivatives by unsaturated fatty acids. Horowitz B; Piët MP; Prince AM; Edwards CA; Lippin A; Walakovits LA Vox Sang; 1988; 54(1):14-20. PubMed ID: 2831669 [TBL] [Abstract][Full Text] [Related]
7. Effects of chlorine, iodine, and quaternary ammonium compound disinfectants on several exotic disease viruses. Shirai J; Kanno T; Tsuchiya Y; Mitsubayashi S; Seki R J Vet Med Sci; 2000 Jan; 62(1):85-92. PubMed ID: 10676896 [TBL] [Abstract][Full Text] [Related]
8. The influence of high temperature on human cells in culture, their sensitivity to viruses and their interferon-producing capacity. Kognovitskaya AI; Bokhonko AI; Mamontova TV; Orlova TG Acta Virol; 1987 Jan; 31(1):7-12. PubMed ID: 2437783 [TBL] [Abstract][Full Text] [Related]
9. Effects of lyophilization on the infectivity of enveloped and non-enveloped viruses in bone tissue. Uhlenhaut C; Dörner T; Pauli G; Pruss A Biomaterials; 2005 Nov; 26(33):6558-64. PubMed ID: 15946737 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis. Vollenbroich D; Ozel M; Vater J; Kamp RM; Pauli G Biologicals; 1997 Sep; 25(3):289-97. PubMed ID: 9324997 [TBL] [Abstract][Full Text] [Related]
11. Photo-inactivation of viruses in therapeutical plasma. Mohr H; Lambrecht B; Schmitt H Dev Biol Stand; 1993; 81():177-83. PubMed ID: 8174801 [TBL] [Abstract][Full Text] [Related]
12. Inactivation of viruses by pasteurization at 60 °C for 10 h with and without 40% glucose as stabilizer during a new manufacturing process of α2-Macroglobulin from Cohn Fraction IV. Huangfu C; Ma Y; Jia J; Lv M; Zhu F; Ma X; Zhao X; Zhang J Biologicals; 2017 Mar; 46():139-142. PubMed ID: 28215695 [TBL] [Abstract][Full Text] [Related]
13. Cross-linking of viral RNA by 4'-aminomethyl-4,5',8-trimethylpsoralen in HeLa cells infected with encephalomyocarditis virus and the tsG114 mutant of vesicular stomatitis virus. Nilsen TW; Wood DL; Baglioni C Virology; 1981 Feb; 109(1):82-93. PubMed ID: 6258315 [No Abstract] [Full Text] [Related]
14. Role of incomplete viruses and interferon in persistent infection of mouse cells with Sindbis virus. Inglot AD; Chudzio T; Albin M Acta Microbiol Pol A; 1973; 5(3):181-2. PubMed ID: 4358717 [No Abstract] [Full Text] [Related]
15. Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus. Belardelli F; Vignaux F; Proietti E; Gresser I Proc Natl Acad Sci U S A; 1984 Jan; 81(2):602-6. PubMed ID: 6320197 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of virus growth produced by thiols and disulphides. Marcialis MA; Flore O; Marongiu ME; Pompei R; La Colla P; Loddo B Experientia; 1977 Aug; 33(8):1044-5. PubMed ID: 196894 [TBL] [Abstract][Full Text] [Related]
17. Pasteurized, monoclonal antibody factor VIII concentrate: establishing a new standard for purity and viral safety of plasma-derived concentrates. Goldsmith JC Blood Coagul Fibrinolysis; 2000 Mar; 11(2):203-15. PubMed ID: 10759015 [TBL] [Abstract][Full Text] [Related]
18. Virus inactivation during production of intravenous immunoglobulin. Kempf C; Jentsch P; Poirier B; Barré-Sinoussi F; Morgenthaler JJ; Morell A; Germann D Transfusion; 1991 Jun; 31(5):423-7. PubMed ID: 1646503 [TBL] [Abstract][Full Text] [Related]
19. Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'Emofilia. Mariani G; Di Paolantonio T; Baklaya R; Morfini M; Mannucci PM Transfusion; 1993 Oct; 33(10):814-8. PubMed ID: 8236421 [TBL] [Abstract][Full Text] [Related]
20. Removal of small non-enveloped viruses by nanofiltration. Yokoyama T; Murai K; Murozuka T; Wakisaka A; Tanifuji M; Fujii N; Tomono T Vox Sang; 2004 May; 86(4):225-9. PubMed ID: 15144526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]